Print Page     Close Window     

SEC Filings

10-Q
BIOTIME INC filed this Form 10-Q on 08/09/2017
Entire Document
 

IN WITNESS WHEREOF, the parties have executed this Warrant as of the date above written.

   
Cell Cure Neurosciences Ltd.
 
   
By:
Dr. Charles Irving
 
Title:
CEO
 

 
Agreed and accepted:
 
     
 
HBL-Hadasit Bio-Holdings Ltd.
 
     
 
By:
   
 
Title:
   
 
[ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
 
23

© Copyright BioTime, Inc.